SHORT_NAME	LONG_NAME	ABSTRACT	CANCER_SITE	PATIENT_ID_NAME	INTEGRATED	OVERALL_ACCESS	SCHEMA_NAME	USE_IN_GUI	CONTENT_TYPES	SHOW_CONTENT_IN_GUI
BRC_ZHOU_2008_01	Expression data from age-dichotomized ER+, N0 breast tumors	Signaling pathways that converge on two different transcription factor complexes, NFKB and AP-1, have been identified in estrogen receptor (ER)-positive breast cancers resistant to the antiestrogen, tamoxifen. In this study, biomarkers co-ordinately up-regulated by NFKB and AP-1 with prognositic significance are identified in a largely TAM-treated set of ER+ node negative breast cancers. The prognostic value with respect to age is also investigated.  <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE7378">http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE7378</a>; <a href="http://www.ncbi.nlm.nih.gov/pubmed/17407600">http://www.ncbi.nlm.nih.gov/pubmed/17407600</a>	BREAST	Sample iid	1	PUBLIC	BRC_ZHOU_2008_01	1	CLINIC, MICROARRAY	1,1